Dr Michelle Remme
in Health Economics
15-17 Tavistock Place
Michelle Remme is an economist and has been working on the economics of HIV and health financing for over 12 years, both at the international and country level. After completing her MSc in International Economics and Finance at Tilburg University, The Netherlands (2005), she worked as a policy officer at the Dutch Ministry of Foreign Affairs and Development Cooperation on the socio-economic dimensions of HIV/AIDS and broader health financing issues. She also spent 3 years in Malawi with the Food and Agriculture Organisation of the United Nations, providing technical assistance on the integration of HIV, gender and food security.
Michelle has consulted for the World Bank, World Health Organisation, Overseas Development Institute, United Nations Development Programme, Medical Research Council of South Africa and Cordaid in Mali, Malawi, the Central African Republic, Burkina Faso and Nigeria. These assignments involved research coordination and implementation, evidence syntheses, baseline survey analysis and project evaluation on a range of topics, including performance-based financing, monetary incentives for community health volunteers, public-private partnerships, aid effectiveness and the economics of violence against women and girls programming.
She has been working at the School since 2011, primarily on the efficiency and financing of HIV programmes. Since 2015, she is also a scientific collaborator with the Ifakara Health Institute, and is based in Dar es Salaam, Tanzania.
Michelle is a tutor and project supervisor for students on the MSc Public Health and the MSc Global Health Policy. She is also a seminar leader on the Introduction to Health Economics module.
Michelle is currently working on research related to the economic evaluation and financing of interventions with multiple HIV, health and development outcomes through co-investments. She is a member of the HIV Modelling & Economics group, as well as the STRIVE Research Programme Consortium (Tackling the structural drivers of HIV).